Patent · US Active

Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

US7763738B2 · kind B2 · utility

23Cited by
24References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2007
Grant dateJul 27, 2010
Priority date
Expiry dateSep 24, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.